COMMUNIQUÉS West-GlobeNewswire

-
VIRBAC: Croissance soutenue du chiffre d’affaires à fin septembre de +12,6% et +8,6% à taux de change et périmètre constants. Maintien des objectifs pour 2024.
17/10/2024 -
Emergex Announces Company Name Change to “Gylden Pharma Limited” Reflecting Company’s Commitment to Advanced Core Technologies and Expanded Product Pipeline
17/10/2024 -
Dr. Wenming Chen to Receive Asian Myeloma Network Distinguished Service Award at the 8th AMN Summit in Seoul
17/10/2024 -
Rapafusyn Pharmaceuticals to Present In Vivo Data on ENT1 Inhibitor for Acute Kidney Injury at the American Society for Nephrology (ASN Kidney Week 2024)
17/10/2024 -
New Study Reveals Promising Outcomes for Minimally Invasive Sacrospinous Ligament Fixation Using EnPlace® for Treating Pelvic Organ Prolapse in Older Women
17/10/2024 -
WellRithms Selected for BenefitsPRO’s 2024 Luminaries Awards
17/10/2024 -
Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
17/10/2024 -
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
17/10/2024 -
TOMI Environmental Solutions, Inc. Announces Record Q3 2024 iHP Corporate Service Revenue
17/10/2024 -
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
17/10/2024 -
Nordic Naturals Completes 40th Annual California Coastal Cleanup with National Retail Support
17/10/2024 -
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton
17/10/2024 -
Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment
17/10/2024 -
Solera Health Study Suggests Virtual Healthcare Networks Can Reduce the Cost of Care by up to 3.1%
17/10/2024 -
Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur
16/10/2024 -
Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe
16/10/2024 -
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
16/10/2024 -
Teladoc Health to Announce Third Quarter 2024 Financial Results
16/10/2024 -
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality
16/10/2024
Pages